Aggressive Promotional Blitz Aims To Shake SSC's Pork Barrel Image

As enthusiastic support for the superconducting supercollider cools off, advocates step up efforts to save the megaproject Proponents of the superconducting supercollider are mounting a vigorous public relations campaign to win over Congress and the United States public and to head off a repeat of last summer's House vote to kill the $8.3 billion project. Funding for the Dallas-based SSC was restored last year only through the 11th-hour mobilization of dozens of physicists to converge

Written byScott Veggeberg
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

As enthusiastic support for the superconducting supercollider cools off, advocates step up efforts to save the megaproject

Funding for the Dallas-based SSC was restored last year only through the 11th-hour mobilization of dozens of physicists to converge on Congress (Scott Veggeberg, The Scientist, Sept. 28, 1992, page 1).

This year, supercollider supporters from both industry and academia are getting their campaign rolling early. And the efforts are beginning to pay off, says Jerry Staub, executive director of the National Association for the Superconducting Super Collider, an SSC-promoting industry association. This organization--with financial support from SSC contractors like St. Louis-based General Dynamics Corp. and Pittsburgh-based Westinghouse Electric Corp.--has "hit the floor running" with the establishment in January of an office on Capitol Hill, Staub says.

"I'm feeling better and better about it all the time," he says. "We're going to win."

Staub maintains: "What we're doing, I think, is the way ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies